Undiscovered cause of Parkinson's found for first time by scientists in huge breakthrough
Scientists have made a potentially 'life-changing' discovery that could pave the way for new drugs to treat Parkinson's disease.
Experts have known for several decades that the PINK1 protein is directly linked to Parkinson's disease – the fastest growing neurodegenerative condition in the world.
Until now, no one has seen what human PINK1 looks like, how PINK1 attaches to the surface of damaged mitochondria inside of cells, or how it is activated.
But scientists have now discovered how the mutation switches on and can start using this knowledge to find a way to switch it off and slow the progression of the condition down.
Researchers at the Walter and Eliza Hall Institute, Parkinson's Disease Research Centre, in Australia, have solved the decades-long mystery.
The findings published in the journal Science reveal for the first time ever the structure of PINK1 and how it binds to mitochondria – the powerhouse of a cell – and stops it functioning properly.
Parkinson's disease can take years, sometimes decades to diagnose. Often associated with tremors, there are close to 40 symptoms including cognitive impairment, speech issues, body temperature regulation and vision problems.
The neurological condition affects around 153,000 Britons. There is currently no cure for Parkinson's, although medicine, physiotherapy and surgery can help manage symptoms.
One of the hallmarks of Parkinson's is the death of brain cells. Around 50 million cells die and are replaced in the human body every minute. But, unlike other cells in the body, when brain cells die, the rate at which they are replaced is extremely low.
When mitochondria are damaged, they stop making energy and release toxins into the cell. In a healthy person, the damaged cells are disposed of in a process called mitophagy.
In a person with Parkinson's and a PINK1 mutation, the mitophagy process no longer functions correctly and toxins accumulate in the cell, eventually killing it. Brain cells need a lot of energy and are especially sensitive to this damage.
In particular, PINK1 has been linked to young-onset Parkinson's Disease, which affects people under the age of 50. Despite the known link, researchers have previously been unable to visualise the protein or how it works.
'This is a significant milestone for research into Parkinson's. It is incredible to finally see PINK1 and understand how it binds to mitochondria,' said Professor David Komander, corresponding author on the study.
'Our structure reveals many new ways to change PINK1, essentially switching it on, which will be life-changing for people with Parkinson's,' he added.
Lead author on the study, Dr Sylvie Callegari, said PINK1 works in four distinct steps, with the first two steps not having been seen before.
First, PINK1 senses mitochondrial damage. Then, it attaches to damaged mitochondria. Once attached, it links to a protein called Parkin so that the damaged mitochondria can be recycled.
'This is the first time we've seen human PINK1 docked to the surface of damaged mitochondria, and it has uncovered a remarkable array of proteins that act as the docking site. We also saw, for the first time, how mutations present in people with Parkinson's disease affect human PINK1,' said Dr Callegari.
The idea of using PINK1 as a target for potential drug therapies has long been touted but not yet achieved because the structure of PINK1 and how it attaches to damaged mitochondria were unknown.
The research team hope to use the knowledge to find a drug to slow or stop Parkinson's in people with a PINK1 mutation.
Researchers in the UK also believe the discovery could lead to better drug design.
Consultant neurologist Dr Richard Ellis said: 'It is a crucial step towards understanding the impact of PINK1 in Parkinson's disease. These observations may hopefully create new opportunities for developing novel strategies for slowing the progression of Parkinson's disease.'
Dr Zhi Yao, research scientist, Life Arc, said: 'A robust understanding of these aspects could present a significant opportunity for accelerating drug discovery for Parkinson's disease and potentially other neurodegenerative conditions too.'
Becky Jones, research communications manager at Parkinson's UK, said: 'Changes in the PINK1 have long been linked to Parkinson's, and a specific mutation in the gene that contains the instructions for making the protein are known to cause a rare inherited form of the condition.
'It's encouraging to see this research, which will help us understand how changes in PINK1 might be causing damage to dopamine-producing brain cells in people with Parkinson's.
'This knowledge unlocks future avenues for better drug design and discovery of a treatment that could slow or even stop Parkinson's progression. This is vital, as despite it being the fastest growing neurological condition in the world, we don't yet have any drug treatments that can do this.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
RFK Jr. will ‘end the war' against alternative medicine at the FDA, from stem cell therapy to chelation. Here's what to know
Health and Human Services Secretary Robert F. Kennedy, Jr. doubled down on his support for non-pharmaceutical health treatments during a recent podcast appearance, saying, 'We're going to end the war at the FDA against alternative medicine.' Speaking on the Ultimate Human podcast with host Gary Brecka, a 'renowned Human Biologist, biohacker, and longevity expert,' according to the website, Kennedy said he would fix the U.S. Food and Drug Administration's bias against the following: stem cell treatments, chelating drugs, vitamins and minerals, amino acids, peptides, and hyperbaric chambers. 'Our position is that the FDA has a job: Just do the science on these kinds of issues and then tell the public what they've learned from the science … but don't tell physicians what they can and cannot prescribe,' he said. And as far as the patients go, he said, 'If you want to take an experimental drug … you ought to be able to do that.' RFK Jr. added, 'We don't want to have the Wild West. We want to make sure that information is out there. But we also want to respect the intelligence of the American people' to decide what treatments will benefit them the most. He acknowledged that, with this approach, there will be 'charlatans' as well as 'people who have bad results' from various alternative treatments. 'But ultimately,' he said, 'you can't prevent that either way, and leaving the whole thing in the hands of pharma is not working for us.' Brecka called Kennedy's pronouncements 'music to my ears.' Below, what you need to know about the alternative therapies RFK Jr. is advocating for. What is it: It's a way to repair diseased or injured tissue in the body using stem cells—cells that can self-renew or become other types of tissues—typically grown in a lab, manipulated, and then be implanted into the patient. What it does: Though it's considered to be largely experimental, the FDA does permit stem cell therapies for blood and immune disorders. Leukemia, lymphoma, neuroblastoma, and multiple myeloma, for example, are also often treated this way, with bone marrow treatments, which are backed by decades of science. Other types of the treatment are still in clinical trials, while more and more wellness centers are offering the treatment for unapproved reasons, using cells drawn from the patient's body and injected back in without manipulation for everything from autism and ALS to Parkinson's and better skin, according to the New York Times. Kennedy told Brecka that he received the treatment for his voice disorder, spasmodic dysphonia, and that it helped him 'enormously,' but that he had to go to Antigua to access it. Risks: For starters, wellness clinic treatments cannot guarantee they are using actual stem cell, reported the Times. And improper injections can lead to a host of terrible consequences—clots, infections, blindness, and even the formation of tumors, which the FDA warned of in 2021. What it is: Chelation involves the use of certain chemicals to remove toxic heavy metals, such as mercury and lead, from the body; all FDA-approved chelation therapy products require a prescription and can only be used safely under the supervision of a healthcare practitioner. What it does: Some alternative medicine practitioners offer chelation therapy, through pill or injection, as a way to treat Alzheimer's, autism, diabetes, high blood pressure, or Parkinson's disease, all of which are unapproved and risky. Children's Health Defense, founded by Kennedy, has written about chelation as a way to treat autism, which compares 'autism with mercury poisoning' due to childhood vaccines that contained the preservative thimerosal (largely mercury) before it was removed in 2001. Some flu shots still contain the preservative, but, says the Centers for Disease Control and Prevention, 'There is no evidence of harm caused by the low doses of thimerosal in vaccines.' Risks: The FDA warns specifically about using chelation therapy for autism, and notes, 'Chelating important minerals needed by the body can lead to serious and life-threatening outcomes.' While minor risks may include fever, headache, muscle pain, and nausea or vomiting, severe reactions range from heart failure and kidney damage to respiratory failure and seizures, according to the Cleveland Clinic. What they are: Dietary supplements in almost every letter of the alphabet, from A to zinc, are over-the-counter pills or liquids that contain nutritional boosts of vitamins and minerals. What they aim to help: Vitamin and mineral supplements aim to fill in with necessary nutrients that a person is not getting through food—though nutritionists believe that healthy food is the best source of such vitamins and minerals. Studies have found supplements may help with practically any issue under the sun—energy, heart issues, cognitive function, gut health, sleep, and more. Risks: The U.S. Food and Drug Administration regulates supplements, but doesn't approve them for safety or effectiveness before they are sold to the public. Some may cause liver damage and toxicity, while others may just be a waste of money. What it is: Amino acids are often referred to as the 'building blocks of proteins,' needed for building proteins, hormones, and neurotransmitters. are compounds that play many critical roles in your body. You need them for vital processes such as building proteins, hormones, and neurotransmitters. Amino acids are concentrated in protein-rich foods such as meat, fish, and soybeans, and foods that contain all nine essential amino acids are called complete proteins. Peptides are short proteins, and come in the form of hormones such as follicle-stimulating hormone (FSH), and creatine and collagen. What they aim to help: Amino acid supplements may help with various issues—such as L-arginine for blood flow and inflammation; tryptophan for mood and sleep; and valine, leucine, and isoleucine to help with energy and athletic performance. Taking collagen supplements may help strengthen nails and bones, while people take creatine for boosting workouts and building muscle growth. Risks: Side effects of taking either can range from toxicity and gastrointestinal issues to effects on brain function muscle protein balance. Creatine may cause muscle cramps and digestive problems (and may not have many benefits), while tryptophan may cause dizziness, headache, or nausea. And again, as with all supplements, the U.S. Food and Drug Administration regulates them, but doesn't approve them for safety or effectiveness before they are sold to the public. What it is: Hyperbaric oxygen therapy in a medical-grade, FDA-approved chamber lets you breathe pure oxygen—as opposed to everyday air, which is just 21% oxygen mixed with nitrogen. Hyperbaric oxygen is also highly pressurized, thereby allowing the lungs to take more in. Home chambers (used by folks including Lebron James, LeAnn Rimes, and Mayim Bialik), as well as those offered in many wellness clinics, do not deliver 100% oxygen. Instead, they use regular air that is 30% more pressurized than normal for what's known as 'mild hyperbarics.' What it aims to help: The FDA has been regulating HBOT chambers since 1976, and has officially cleared 13 medical conditions—such as decompression sickness, burns, radiation injury, and certain wounds—for such treatment. But it's used off-label for many other reasons, including concussions, traumatic brain injury, long COVID, age reversal, stroke recovery, fibromyalgia, and improved brain function, many of which are being looked at in ongoing clinical trials. Risks: For medical-grade chambers, risks include ear and sinus pain, middle ear injuries, temporary vision changes, and lung collapse, which is rare, according to the FDA. For mild hyperbarics, risks include potential exposure to toxic oils from some compressors, carbon dioxide buildup that brings a risk of hypoxia inside the chamber—or, according to some experts and a body of inconclusive evidence, that the treatment may simply be ineffective. This story was originally featured on
New York Times
a day ago
- New York Times
The Humanist Who Designed a Deadly Weapon
Times Insider explains who we are and what we do and delivers behind-the-scenes insights into how our journalism comes together. Once, during an interview, I saw him in action as he described a run of knotty calculations he was doing in his head — the kind of math his peers usually worked out on paper or with computers. That gift was surely one reason that Enrico Fermi, a founder of the nuclear age who mentored him at the University of Chicago, called Richard L. Garwin 'the only true genius I have ever met.' It also played to a popular image of Dr. Garwin as slightly robotic, even computerlike, a thinking machine that happened to have legs. Dr. Garwin died last month at 97, leaving behind a legacy of contradictions. In 1951, at age 23, he designed the first hydrogen bomb, the world's deadliest weapon, a planet shaker that could end civilization. He then devoted his life to counteracting the terror. Over four decades of interviews, chats and social interactions, I learned that the man behind the stereotypes was full of surprises, which I wrote about in a recent article. He had a reputation for being cruel to those he saw as less talented. That may have been true in the prime of his professional life. But in person during his later years, Dr. Garwin came across as a gentle academic, a humanist whose life turned out to be rich in benevolent acts. Years ago, Gene Cittadino, a friend of mine who taught science history at New York University, asked me if Dr. Garwin might be willing to speak to his class. After the talk, Gene and several students took him to lunch and were regaled with stories about the presidents he advised. 'He was soft-spoken, sharp as a tack and funny,' Gene recalled. The whiz, he added, 'treated us with respect,' as if we were his colleagues. Want all of The Times? Subscribe.
Yahoo
a day ago
- Yahoo
Police search for missing Lake County man
PEACOCK TOWNSHIP, Mich. (WOOD) — Police are asking the public for help finding a Lake County man who was last seen Sunday. Jack Albert Peterson, 67, stands 6 feet, 6 inches tall and weighs about 200 pounds. He has green eyes and brown graying hair. According to Michigan State Police, Peterson was last seen Sunday near Irons Road and 4 Mile Road in Irons. He left his vehicle, phone and other personal belongings at home, troopers say. Peterson has Parkinson's disease, MSP said. Anyone who knows where he may be should contact Lake County Central Dispatch at 231.745.2711. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
